Lifecore Biomedical, Inc. LFCR EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s EPS (diluted)?
- Lifecore Biomedical, Inc. (LFCR) reported EPS (diluted) of -$0.43 in Q1 2026.
- How has Lifecore Biomedical, Inc.'s EPS (diluted) changed year-over-year?
- Lifecore Biomedical, Inc.'s EPS (diluted) decreased by 1333.3% year-over-year, from -$0.03 to -$0.43.
- What is the long-term trend for Lifecore Biomedical, Inc.'s EPS (diluted)?
- Over 2 years (2022 to 2025), Lifecore Biomedical, Inc.'s EPS (diluted) has grown at a -44.3% compound annual growth rate (CAGR), from -$3.97 to -$1.23.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.